Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has granted an approval to Endo Pharmaceuticals' Felodipine Extended-release (XR) Tablets USP, 2.5mg, 5mg and 10mg.
Subscribe to our email newsletter
Felodipine XR Tablets are the generic equivalent to AstraZeneca’s Plendil XR Tablets.
The company’s generic business unit – Qualitest Pharmaceuticals will manufacture and distribute the Felodipine XR Tablets.
Endo Pharma develops products in areas such as endocrinology, oncology, pain management, pelvic health and urology.